XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Balance at beginning of period (shares) at Dec. 31, 2020   50,439,069      
Balance at beginning of period at Dec. 31, 2020 $ 1,360,789 $ 50 $ 2,481,218 $ 9,759 $ (1,130,238)
Increase (Decrease) in Stockholders' Equity          
Net loss (302,110)       (302,110)
Share-based compensation expense 52,691   52,691    
Issuance of common stock from ESPP (shares)   9,029      
Issuance of common stock from ESPP 1,214   1,214    
Issuance of common stock under equity incentive plans (shares)   537,032      
Issuance of common stock under equity incentive plans $ 16,494 $ 1 16,493    
Net exercise of warrants (shares) 623,814 623,814      
Net exercise of warrants $ 0 $ 1 (1)    
Unrealized gain (loss) on investments (158)     (158)  
Balance at end of period (shares) at Jun. 30, 2021   51,608,944      
Balance at end of period at Jun. 30, 2021 1,128,920 $ 52 2,551,615 9,601 (1,432,348)
Balance at beginning of period (shares) at Mar. 31, 2021   51,375,786      
Balance at beginning of period at Mar. 31, 2021 1,259,413 $ 51 2,515,824 9,456 (1,265,918)
Increase (Decrease) in Stockholders' Equity          
Net loss (166,430)       (166,430)
Share-based compensation expense 27,969   27,969    
Issuance of common stock from ESPP (shares)   9,029      
Issuance of common stock from ESPP 1,214   1,214    
Issuance of common stock under equity incentive plans (shares)   224,129      
Issuance of common stock under equity incentive plans 6,609 $ 1 6,608    
Unrealized gain (loss) on investments 145     145  
Balance at end of period (shares) at Jun. 30, 2021   51,608,944      
Balance at end of period at Jun. 30, 2021 $ 1,128,920 $ 52 2,551,615 9,601 (1,432,348)
Balance at beginning of period (shares) at Dec. 31, 2021 55,356,904 55,356,904      
Balance at beginning of period at Dec. 31, 2021 $ 1,397,038 $ 55 3,099,937 9,068 (1,712,022)
Increase (Decrease) in Stockholders' Equity          
Net loss (364,831)       (364,831)
Share-based compensation expense 81,589   81,589    
Issuance of common stock from ESPP (shares)   29,891      
Issuance of common stock from ESPP 995   995    
Issuance of common stock under equity incentive plans (shares)   205,836      
Issuance of common stock under equity incentive plans 2,924 $ 1 2,923    
Unrealized gain (loss) on investments $ (5,711)     (5,711)  
Balance at end of period (shares) at Jun. 30, 2022 55,592,631 55,592,631      
Balance at end of period at Jun. 30, 2022 $ 1,112,004 $ 56 3,185,444 3,357 (2,076,853)
Balance at beginning of period (shares) at Mar. 31, 2022   55,511,476      
Balance at beginning of period at Mar. 31, 2022 1,249,282 $ 56 3,145,368 4,266 (1,900,408)
Increase (Decrease) in Stockholders' Equity          
Net loss (176,445)       (176,445)
Share-based compensation expense 38,684   38,684    
Issuance of common stock from ESPP (shares)   29,891      
Issuance of common stock from ESPP 995   995    
Issuance of common stock under equity incentive plans (shares)   51,264      
Issuance of common stock under equity incentive plans 397   397    
Unrealized gain (loss) on investments $ (909)     (909)  
Balance at end of period (shares) at Jun. 30, 2022 55,592,631 55,592,631      
Balance at end of period at Jun. 30, 2022 $ 1,112,004 $ 56 $ 3,185,444 $ 3,357 $ (2,076,853)